10.5 C
London
Friday, March 29, 2024
HomeTagsPharmAust

Tag: PharmAust

PharmAust: Completes enrolment of second patient cohort in MND/ALS trial

PharmAust Completes enrolment of second patient cohort in MND/ALS trialPharmAust (PAA) completes the enrolment of the second cohort of patients in its phase...

PharmAust: Reports ongoing positive outcomes for canine cancer treatment

PharmAust Reports ongoing positive outcomes for canine cancer treatmentPharmAust (PAA) claims a 12-year-old beagle in its clinical trial for the treatment of canine...

PharmAust: Gets approval to increase dosage in MPL trial

PharmAust Gets approval to increase dosage in MPL trialPharmAust (PAA) has received the green light from the trial safety committee to increase the...

PharmAust: Receives first $200k instalment for Phase 1 MND trial, appoints trial manager

PharmAust Receives first $200k instalment for Phase 1 MND trial, appoints trial managerClinical-stage biotechnology company PharmAust (PAA) receives over $201,000 under the first...

PharmAust: Successfully produces smaller GMP tablets

PharmAust Successfully produces smaller GMP tabletsPharmAust’s (PAA) upcoming human trials receives a major boost as the company’s GMP monepantel (MPL) tablets has been...

PharmAust: Completes investigations on COVID-19 infection agent

PharmAust: Completes investigations on COVID-19 infection agentPharmAust (PAA) has investigated the effects of monepantel (MPL) and monepantel sulfone (MPLS) on SARS-CoV2 infection, the...

PharmAust: Begins recruiting dogs for canine cancer trial

PharmAust (PAA) has officially started recruiting patients for a second-phase clinical trial testing one of its key drugs against cancer in dogs The...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read